What is the recommended dosing, administration schedule, and monitoring for oral urea 15 g packets in patients with chronic mild‑to‑moderate hyponatraemia?

Oral Urea 15g Packets for Chronic Mild-to-Moderate Hyponatremia

For chronic mild-to-moderate hyponatremia due to SIADH, start with oral urea 15g twice daily (30g/day total), monitor serum sodium every 24 hours initially, and expect normalization within 5-14 days in most patients.

Dosing Strategy

The standard approach is 30g/day divided into two 15g doses (morning and evening), though this can be adjusted based on patient factors 1, 2:

• Initial dose: 15g twice daily (0.25-0.50 g/kg/day)
• Dose range: 15-60g/day depending on severity and response
• Severe hyponatremia (<120 mEq/L): May require 30g twice daily (60g total) 3, 4
• Mild hyponatremia (130-135 mEq/L): Often responds to 15g twice daily

Key dosing principle: Higher cumulative doses produce greater sodium correction, but this must be balanced against overcorrection risk 1.

Administration Schedule

• Timing: Administer twice daily, typically morning and evening
• Duration: Continue until serum sodium normalizes (≥135 mEq/L), typically 4-7 days 5, 2
• Long-term use: Can be continued for months to years in chronic SIADH at 15-30g/day 3
• Combination therapy: Often combined with mild fluid restriction (1.5-2L/day) for first 48 hours, though urea alone is effective 1, 3

Monitoring Protocol

Initial phase (first 48-72 hours):

• Serum sodium: Every 24 hours 5, 2
• Blood urea nitrogen (BUN): Baseline and at sodium normalization
• Clinical symptoms: Daily assessment

After stabilization:

• Serum sodium: Every 2-3 days until normalized
• Once stable: Weekly to monthly monitoring for chronic therapy 3

Expected Response

Timeline for sodium correction 1, 6, 5, 4:

• 24 hours: Mean increase of 2-5 mEq/L
• 48 hours: Mean increase of 4-6 mEq/L
• 5-7 days: Normalization in 55-62% of patients
• 14 days: Normalization in 55-70% of patients
• 30 days: Normalization in 86% of patients

Factors predicting greater response 1:

• Older age (each decade adds ~0.09 mEq/L to correction rate)
• Lower baseline sodium (<125 mEq/L)
• Higher cumulative urea dose
• Initial fluid restriction (first 48 hours only)

Critical Safety Considerations

Overcorrection risk: Occurs in only 3-8% of patients, significantly lower than with hypertonic saline 1, 5, 2. The gradual mechanism of action makes osmotic demyelination syndrome extremely rare—no cases reported in recent studies 1, 5.

Correction limits: While guidelines recommend not exceeding 8 mEq/L in 24 hours for chronic hyponatremia 7, urea's osmotic mechanism naturally prevents rapid overcorrection in most cases.

Tolerability issues 6, 5, 2:

• Poor taste: Most common complaint (54-70% of patients)
• Nausea: Occasional, rarely requires discontinuation
• Discontinuation rate: 11-20% due to side effects, primarily taste aversion
• BUN elevation: Expected and not clinically significant; mean increase from 18 to 41 mg/dL 2

Clinical Context and Pitfalls

When urea is most appropriate:

• SIADH confirmed (93% of urea studies) 1
• Fluid restriction failed or not tolerated
• Chronic/subacute hyponatremia (not acute symptomatic)
• Outpatient management needed (though cost may be prohibitive) 2

Common pitfall: The neurosurgical guidelines 7 describe urea use at 40g every 8 hours (120g/day total) with continuous IV saline for acute neurosurgical hyponatremia—this is a completely different indication and dosing strategy than chronic mild-to-moderate SIADH. Do not confuse these protocols.

Comparison to alternatives 4, 8:

• Versus fluid restriction: Equally effective but better tolerated
• Versus tolvaptan: Similar efficacy (62-63% normalization), but tolvaptan achieves normalization faster (21 vs 42 days) 4
• Versus no treatment: Clearly superior (mean difference 8 mEq/L) 8

Patient selection consideration: Urea works best when baseline urine osmolality is <400 mOsm/kg 3. Patients with very concentrated urine (>600 mOsm/kg) may require higher doses (30g twice daily).

Practical Implementation

1. Confirm SIADH diagnosis (euvolemic, urine osmolality >100 mOsm/kg, urine sodium >30 mEq/L)
2. Start 15g twice daily with or without mild fluid restriction (1.5-2L/day)
3. Check sodium at 24 hours: Expect 2-5 mEq/L rise
4. Adjust dose if needed: Increase to 30g twice daily if inadequate response after 48 hours
5. Continue until normalized: Typically 5-14 days
6. Address taste: Mix with juice or flavored beverages to improve palatability